综述专论

生长激素作用通路、调控机制及生物学活性测定研究进展*

展开
  • 中国食品药品检定研究院 国家卫生健康委员会生物技术产品检定方法及其标准化重点实验室,北京 102629
第一作者 Tel:(010)53851289;E-mail:zhangxm@nifdc.org.cn
** Tel:(010)53851638;E-mail:liangchenggang@nifdc.org.cn

收稿日期: 2022-08-22

  网络出版日期: 2024-06-25

基金资助

* 中国食品药品检定研究院中青年发展研究基金(2022A1)

Research progress on the action pathways, regulation mechanism and biological activity measurement of growth hormone*

Expand
  • National Institutes for Food and Drug Control, NHC Key Laboratory of Research on Quality and Standardization of Biotech Products, Beijing 102629, China

Received date: 2022-08-22

  Online published: 2024-06-25

摘要

生长激素是由脑垂体前叶嗜酸性细胞分泌的1种单一肽链的蛋白质激素,是人出生后促生长最重要的激素。生长激素通过与细胞表面特异性受体结合,激活非受体酪氨酸激酶JAK2及Src家族激酶的下游信号通路发挥生物学效应。深入了解生长激素作用机制是其生物学活性测定研究的基础。本文综述了近年来生长激素相关研究进展,包括生长激素与受体作用机制,生长激素与受体结合后激活的STATs、PI3K-Akt和MEK-Erk等信号通路,以及生长激素作用通路调控机制,并对生长激素活性测定方法研究进行了总结和展望,以期为生长激素药物生物学活性质量控制研究提供参考。

本文引用格式

张孝明, 李晶, 梁成罡 . 生长激素作用通路、调控机制及生物学活性测定研究进展*[J]. 药物分析杂志, 2022 , 42(11) : 1865 -1876 . DOI: 10.16155/j.0254-1793.2022.11.01

Abstract

Growth hormone is a protein hormone with a single peptide chain produced and released by the anterior pituitary, which is the most important hormone for growth promotion after birth. In order to exert biological effects, growth hormone first binds to a specific receptor on the cell surface, and then activates the down stream signaling pathways of the non-receptor tyrosine kinase JAK2 and Src family kinases. An in-depth understanding of the mechanism of action of growth hormone is required for its biological activity measurement. In this paper, we reviewed the recent research progress on growth hormone, including the mechanism of action of growth hormone receptor, the activation of STATs, PI3K-Akt and MEK-Erk signaling pathways by the binding of growth hormone to the receptor, and the regulatory mechanism of growth hormone action pathways. We also summarized and prospected the research on the determination methods of growth hormone activity, in order to provide a reference for the quality control of the biological activity of growth hormone drugs.

参考文献

[1] LIU YX, CHEN JY, TANG XL, et al. The 20 kDa and 22 kDa forms of human growth hormone (hGH) exhibit different intracellular signalling profiles and properties[J].Gen Comp Endocrinol, 2017, 248(7): 49
[2] STRASBURGER CJ, DATTANI MT. New growth hormone assays: potential benefits[J].Acta Paediatr Suppl, 1997, 86(S423): 5
[3] DEHKHODA F, LEE CMM, MEDINA J, et al. The growth hormone receptor: mechanism of receptor activation, cell signaling, and physiological aspects[J].Front Endocrinol (Lausanne), 2018, 13(9): 35
[4] LEUNG DW, SPENCER SA, CACHIANES G, et al. Growth hormone receptor and serum binding protein: purification, cloning and expression[J].Nature, 1987, 330(6148): 537
[5] DE-VOSAM, ULTSCH M, KOSSIAKOFF AA. Human growth hormone and extracellular domain of its receptor: crystal structure of the complex[J].Science, 1992, 255(5042): 306
[6] CUNNINGHAM BC, ULTSCH M, DE-VOS AM, et al. Dimerization of the extracellular domain of the human growth hormone receptor by a single hormone molecule[J].Science, 1991, 254(5033): 821
[7] GENT J, VANKERKHOF P, ROZA M, et al. Ligand-independent growth hormone receptor dimerization occurs in the endoplasmic reticulum and is required for ubiquitin system-dependent endocytosis[J].Proc Natl Acad Sci USA, 2002, 99(15): 9858
[8] BROWN RJ, ADAMS JJ, PELEKANOS RA, et al. Model for growth hormone receptor activation based on subunit rotation within a receptor dimer[J].Nat Struct Mol Biol, 2005, 12(9): 814
[9] GENT J, EIJNDEN MVD, KERKHOF PV, et al. Dimerization and signal transduction of the growth hormone receptor[J].Mol Endocrinol, 2003, 17(5): 967
[10] LIU Y, ZHANG Y, JIANG J, et al. GHR/PRLR heteromultimer is composed of ghr homodimers and PRLR homodimers[J].Mol Endocrinol, 2016, 30(5): 504
[11] SOTIROPOULOS A, MOUTOUSSAMY S, RENAUDIE F, et al. Differential activation of Stat 3 and Stat 5 by distinct regions of the growth hormone receptor[J].Mol Endocrinol, 1996, 10(8): 998
[12] CHILTON BS, HEWETSON A. Prolactin and growth hormone signaling[J].Curr Top Dev Biol, 2005, 68(8): 1
[13] ZHOU Y, XU BC, MAHESHWARI HG, et al. A mammalian model for Laron syndrome produced by targeted disruption of the mouse growth hormone receptor/binding protein gene (the Laron mouse)[J].Proc Natl Acad Sci USA, 1997, 94(24): 13215
[14] ARGETSINGER LS, CAMPBELL GS, YANG X, et al. Identification of JAK2 as a growth hormone receptor-associated tyrosine kinase[J].Cell, 1993, 74(2): 237
[15] FRANK SJ. Classical and novel GH receptor signaling pathways[J].Mol Cell Endocrinol, 2020, 518(12): 110999
[16] NEUBAUER H, CUMANO A, MÜLLER M, et al. Jak 2 deficiency defines an essential developmental checkpoint in definitive hematopoiesis[J].Cell, 1998, 93(3): 397
[17] SOS BC, HARRIS C, NORDSTROM SM, et al. Abrogation of growth hormone secretion rescues fatty liver in mice with hepatocyte-specific deletion of JAK 2[J].J Clin Invest, 2011, 121(4): 1412
[18] SMIT LS, MEYER DJ, BILLESTRUP N, et al. The role of the growth hormone (GH) receptor and JAK1 and JAK2 kinases in the activation of Stats 1, 3, and 5 by GH[J].Mol Endocrinol, 1996, 10(5): 519
[19] HAN Y, LEAMAN DW, WATLING D, et al. Participation of JAK and STAT proteins in growth hormone-induced signaling[J].J Biol Chem, 1996, 271(10): 5947
[20] GRONOWSKI AM, ROTWEIN P. Rapid changes in nuclear protein tyrosine phosphorylation after growth hormone treatment in vivo. Identification of phosphorylated mitogen-activated protein kinase and STAT91[J].J Biol Chem, 1994, 269(11): 7874
[21] CAMPBELL GS, MEYER DJ, RAZ R, et al. Activation of acute phase response factor (APRF)/Stat 3 transcription factor by growth hormone[J].J Biol Chem, 1995, 270(8): 3974
[22] BARCLAY JL, KERR LM, ARTHUR L, et al. In vivo targeting of the growth hormone receptor (GHR) Box 1 sequence demonstrates that the GHR does not signal exclusively through JAK 2[J].Mol Endocrinol, 2010, 24(1): 204
[23] ROWLAND JE, LICHANSKA AM, KERR LM, et al. In vivo analysis of growth hormone receptor signaling domains and their associated transcripts[J].Mol Cell Biol, 2005, 25(1): 66
[24] HWA V. STAT5B deficiency: impacts on human growth and immunity[J].Growth Horm IGF Res, 2016, 28: 16
[25] ZHANG Y, LAZ EV, WAXMAN DJ. Dynamic, sex-differential STAT5 and BCL6 binding to sex-biased, growth hormone-regulated genes in adult mouse liver[J].Mol Cell Biol, 2012, 32(4): 880
[26] CARTER-SU C, KING AP, ARGETSINGER LS, et al. Signalling pathway of GH[J].Endocr J, 1996, 43(10):S65
[27] ZEHORAI E, YAO Z, PLOTNIKOV A, et al. The subcellular localization of MEK and ERK——a novel nuclear translocation signal (NTS) paves a way to the nucleus[J].Mol Cell Endocrinol, 2010, 314(2): 213
[28] GURLAND G, ASHCOM G, COCHRAN BH, et al. Rapid events in growth hormone action. Induction of c-fos and c-jun transcription in 3T3-F442A preadipocytes[J].Endocrinology, 1990, 127(6): 3187
[29] HODGE C, LIAO J, STOFEGA M, et al. Growth hormone stimulates phosphorylation and activation of elk-1 and expression of c-fos, egr-1, and jun B through activation of extracellular signal-regulated kinases 1 and 2[J].J Biol Chem, 1998, 273(47): 31327
[30] CUI TX, KWOK R, SCHWARTZ J. Cooperative regulation of endogenous cAMP-response element binding protein and CCAAT/enhancer-binding protein beta in GH-stimulated c-fos expression[J].J Endocrinol, 2008, 196(1): 89
[31] KOUZARIDES T. Chromatin modifications and their function[J].Cell, 2007, 128(4): 693
[32] HANSBERG-PASTOR V, PIÑA-MEDINA AG, GONZÁLEZ-ARENAS A, et al. C/EBPβ isoforms expression in the rat brain during the estrous cycle[J].Int J Endocrinol, 2015, 2015(4): 674915
[33] ARGETSINGER LS, HSU GW, MYERS-Jr MG, et al. Growth hormone, interferon-gamma, and leukemia inhibitory factor promoted tyrosyl phosphorylation of insulin receptor substrate-1[J].J Biol Chem, 1995, 270(24): 14685
[34] ARGETSINGER LS, NORSTEDT G, BILLESTRUP N, et al. Growth hormone, interferon-gamma, and leukemia inhibitory factor utilize insulin receptor substrate-2 in intracellular signaling[J].J Biol Chem, 1996, 271(46): 29415
[35] ALESSI DR, JAMES SR, DOWNES CP, et al. Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Balpha[J].Curr Biol, 1997, 7(4): 261
[36] PIWIEN-PILIPUK G, VAN-MATER D, ROSS SE, et al. Growth hormone regulates phosphorylation and function of CCAAT/enhancer-binding protein beta by modulating Akt and glycogen synthase kinase-3[J].J Biol Chem, 2001, 276(22): 19664
[37] MEYER DJ, CAMPBELL GS, COCHRAN BH, et al. Growth hormone induces a DNA binding factor related to the interferon-stimulated 91-kDa transcription factor[J].J Biol Chem, 1994, 269(7): 4701
[38] DURBIN JE, HACKENMILLER R, SIMON MC, et al. Targeted disruption of the mouse Stat 1 gene results in compromised innate immunity to viral disease[J].Cell, 1996, 84(3): 443
[39] CHIA DJ. Minireview: mechanisms of growth hormone-mediated gene regulation[J].Mol Endocrinol, 2014, 28(7): 1012
[40] NIELSEN C, GORMSEN LC, JESSEN N, et al. Growth hormone signaling in vivo in human muscle and adipose tissue: impact of insulin, substrate background, and growth hormone receptor blockade[J].J Clin Endocrinol Metab, 2008, 93(7): 2842
[41] VESTERGAARD PF, VENDELBO MH, PEDERSEN SB, et al. GH signaling in skeletal muscle and adipose tissue in healthy human subjects: impact of gender and age[J].Eur J Endocrinol, 2014, 171(5): 623
[42] OBERBAUER AM. The regulation of IGF-1 gene transcription and splicing during development and aging[J].Front Endocrinol (Lausanne), 2013,26(3): 4
[43] ROTWEIN P. Regulation of gene expression by growth hormone[J].Mol Cell Endocrinol, 2020, 507(5): 110788
[44] ALZHANOV D, MUKHERJEE A, ROTWEIN P. Identifying growth hormone-regulated enhancers in the IGF 1 locus[J].Physiol Genomics, 2015, 47(11): 559
[45] MUKHERJEE A, ALZHANOV D, ROTWEIN P. Defining human insulin-like growth factor I gene regulation[J].Am J Physiol Endocrinol Metab, 2016, 311(2): E519
[46] CHIA DJ, ROTWEIN P. Defining the epigenetic actions of growth hormone: acute chromatin changes accompany GH-activated gene transcription[J].Mol Endocrinol, 2010, 24(10): 2038
[47] OUNI M, BELOT MP, CASTELL AL, et al. The P 2 promoter of the IGF 1 gene is a major epigenetic locus for GH responsiveness[J].Pharmacogenomics J, 2016, 16(1): 102
[48] WU S, MORRISON A, SUN H, et al. Nuclear factor-kappaB (NF-kappaB) p65 interacts with Stat5b in growth plate chondrocytes and mediates the effects of growth hormone on chondrogenesis and on the expression of insulin-like growth factor-1 and bone morphogenetic protein-2[J].J Biol Chem, 2011, 286(28): 24726
[49] UMAYAHARA Y, BILLIARD JJIC. CCAAT/enhancer-binding protein delta is a critical regulator of insulin-like growth factor-I gene transcription in osteoblasts[J].J Biol Chem, 1999, 274(15): 10609
[50] ZHU T, LING L, LOBIE PE. Identification of a JAK2-independent pathway regulating growth hormone (GH)-stimulated p44/42 mitogen-activated protein kinase activity. GH activation of Ral and phospholipase D is Src-dependent[J].J Biol Chem, 2002, 277(47): 45592
[51] ZHU T, GOH EL, LEROITH D, et al. Growth hormone stimulates the formation of a multiprotein signaling complex involving p130(Cas) and CrkII. Resultant activation of c-Jun N-terminal kinase/stress-activated protein kinase (JNK/SAPK)[J].J Biol Chem, 1998, 273(50): 33864
[52] WANG X, HE K, GERHART M, et al. Metalloprotease-mediated GH receptor proteolysis and GHBP shedding. Determination of extracellular domain stem region cleavage site[J].J Biol Chem, 2002, 277(52): 50510
[53] ZHANG Y, WANG X, LOESCH K, et al. TIMP3 modulates GHR abundance and GH sensitivity[J].Mol Endocrinol, 2016, 30(6): 587
[54] GUAN R, ZHANG Y, JIANG J, et al. Phorbol ester- and growth factor-induced growth hormone (GH) receptor proteolysis and GH-binding protein shedding: relationship to GH receptor down-regulation[J].Endocrinology, 2001, 142(3): 1137
[55] WANG X, JIANG J, WARRAM J, et al. Endotoxin-induced proteolytic reduction in hepatic growth hormone (GH) receptor: a novel mechanism for GH insensitivity[J].Mol Endocrinol, 2008, 22(6): 1427
[56] DAVEY HW, MCLACHLAN MJ, WILKINS RJ, et al. STAT5b mediates the GH-induced expression of SOCS-2 and SOCS-3 mRNA in the liver[J].Mol Cell Endocrinol, 1999, 158(1-2): 111
[57] UNGUREANU D, SAHARINEN P, JUNTTILA I, et al. Regulation of Jak2 through the ubiquitin-proteasome pathway involves phosphorylation of Jak 2 on Y1007 and interaction with SOCS-1[J].Mol Cell Biol, 2002, 22(10): 3316
[58] CHHABRA Y, WONG HY, NIKOLAJSEN LF, et al. A growth hormone receptor SNP promotes lung cancer by impairment of SOCS 2-mediated degradation[J].Oncogene, 2018, 37(4): 489
[59] PASQUALI C, CURCHOD ML, WÄLCHLI S, et al. Identification of protein tyrosine phosphatases with specificity for the ligand-activated growth hormone receptor[J].Mol Endocrinol, 2003, 17(11): 2228
[60] RAM PA, WAXMAN DJ. Interaction of growth hormone-activated STATs with SH2-containing phosphotyrosine phosphatase SHP-1 and nuclear JAK2 tyrosine kinase[J].J Biol Chem, 1997, 272(28): 17694
[61] STOFEGA MR, HERRINGTON J, BILLESTRUP N, et al. Mutation of the SHP-2 binding site in growth hormone (GH) receptor prolongs GH-promoted tyrosyl phosphorylation of GH receptor, JAK2, and STAT5B[J].Mol Endocrinol, 2000, 14(9): 1338
[62] PILECKA I, PATRIGNANI C, PESCINI R, et al. Protein-tyrosine phosphatase H1 controls growth hormone receptor signaling and systemic growth[J].J Biol Chem, 2007, 282(48): 35405
[63] RUI L, MATHEWS LS, HOTTA K, et al. Identification of SH2-Bbeta as a substrate of the tyrosine kinase JAK2 involved in growth hormone signaling[J].Mol Cell Biol, 1997, 17(11): 6633
[64] RUI L, CARTER-SU C. Identification of SH2-bbeta as a potent cytoplasmic activator of the tyrosine kinase Janus kinase 2[J].Proc Natl Acad Sci USA, 1999, 96(13): 7172
[65] SU HW, LANNING NJ, MORRIS DL, et al. Phosphorylation of the adaptor protein SH2B1β regulates its ability to enhance growth hormone-dependent macrophage motility[J].J Cell Sci, 2013, 126(Pt 8): 1733
[66] HUANG Y, KIM SO, YANG N, et al. Physical and functional interaction of growth hormone and insulin-like growth factor-I signaling elements[J].Mol Endocrinol, 2004, 18(6): 1471
[67] GAN Y, ZHANG Y, DIGIROLAMO DJ, et al. Deletion of IGF-I receptor (IGF-IR) in primary osteoblasts reduces GH-induced STAT5 signaling[J].Mol Endocrinol, 2010, 24(3): 644
[68] GAN Y, ZHANG Y, BUCKELS A, et al. IGF-1R modulation of acute GH-induced STAT5 signaling: role of protein tyrosine phosphatase activity[J].Mol Endocrinol, 2013, 27(11): 1969
[69] STRASBURGER CJ, WU Z, PFLAUM CD, et al. Immunofunctional assay of human growth hormone (hGH) in serum: a possible consensus for quantitative hGH measurement[J].J Clin Endocrinol Metab, 1996, 81(7): 2613
[70] 中华人民共和国药典2020年版. 四部[S].2020: 530
ChP 2020. Vol Ⅳ[S].2020: 530
[71] USP 2021-NF 39[S/OL].[2021-05-01]. https://online.uspnf.com/uspnf/search?query=Somatropinbioidentitytests
[72] 梁誉龄,高学军,李湛军,等. 重组人生长激素体内生物活性测定中美药典方法对比研究[J].中国药事, 2020, 34(6): 658
LIANG YL,GAO XJ, LI ZJ, et al. A comparative study on Chinese Pharmacopeia and U. S. Pharmacopeia methods for rhGH in vivo bioactivty[J].Chin Pharm Aff, 2020, 34(6): 658
[73] BELLINI MH, BARTOLINI P. In vivo bioassay for the potency determination of human growth hormone in dwarf “little” mice[J].Endocrinology, 1993, 132(5): 2051
[74] TANAKA T, SHIU RP, GOUT PW, et al. A new sensitive and specific bioassay for lactogenic hormones: measurement of prolactin and growth hormone in human serum[J].J Clin Endocrinol Metab, 1980, 51(5): 1058
[75] FUH G, CUNNINGHAM BC, FUKUNAGA R, et al. Rational design of potent antagonists to the human growth hormone receptor[J].Science, 1992, 256(5064): 1677
[76] WADA M, UCHIDA H, IKEDA M, et al. The 20-kilodalton (kDa) human growth hormone (hGH) differs from the 22-kDa hGH in the complex formation with cell surface hGH receptor and hGH-binding protein circulating in human plasma[J].Mol Endocrinol, 1998, 12(1): 146
[77] ISHIKAWA M, NIMURA A, HORIKAWA R, et al. A novel specific bioassay for serum human growth hormone[J].J Clin Endocrinol Metab, 2000, 85(11): 4274
[78] IKEDA M, WADA M, FUJITA Y, et al. A novel bioassay based on human growth hormone (hGH) receptor mediated cell proliferation: measurement of 20K-hGH and its modified forms[J].Growth Horm IGF Res, 2000, 10(5): 248
[79] WANG L, YU C, WANG J. Development of reporter gene assays to determine the bioactivity of biopharmaceuticals[J].Biotechnol Adv, 2020, 39: 107466
[80] ANDERSSON R, SANDELIN A. Determinants of enhancer and promoter activities of regulatory elements[J].Nat Rev Genet, 2020, 21(2): 71
[81] YAO W, YU L, FAN W, et al. A cell-based strategy for bioactivity determination of long-acting Fc-fusion recombinant human growth hormone[J].Molecules, 2019, 24(7): 1389
[82] YANG Y, ZHOU Y, YU L, et al. A novel reporter gene assay for recombinant human erythropoietin (rHuEPO) pharmaceutical products[J].J Pharm Biomed Anal, 2014, 100(11): 316
[83] DECKER T, KOVARIK P, MEINKE A. GAS elements: a few nucleotides with a major impact on cytokine-induced gene expression[J].J Interferon Cytokine Res, 1997, 17(3): 121
文章导航

/